Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Intrauterine Devices Market

U.S. Intrauterine Devices Market Share

  • Report ID: GMI2895
  • Published Date: Mar 2023
  • Report Format: PDF

U.S. Intrauterine Devices Market Share

Some leading U.S. intrauterine devices market players include

  • Bayer AG
  • Allergan (AbbVie, Inc.)
  • and CooperSurgical Inc.

Many of these firms are focusing on product innovations and FDA approvals to sustain their industry leadership. Citing an instance, in August 2021, Bayer AG, a German multinational pharma and biotech firm, received U.S. FDA approval for a supplemental new drug application which extends the use of its IUD Mirena® 52 mg to make it usable for up to 8 years. 
 

Furthermore, results from a phase 3 extension trial which analyzes the safety and efficacy of Mirena serve as the foundation of this approval. This strategic move benefitted the company by enhancing its product portfolio of IUDs, which boosted its revenue. 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

U.S. market for intrauterine devices recorded a valuation of more than USD 1.3 billion In 2022 and is projected to grow at more than 9.5% CAGR from 2023 to 2032, on account of supportive regulatory policies.

U.S. hormonal IUD industry size is anticipated to show a growth rate of over 10% through 2023 to 2032, owing to its non-contraceptive benefits and 99% efficacy.

South Atlantic U.S. intrauterine devices market held a revenue share over 20% in 2022, growth is likely to come from rising awareness about novel contraceptive devices comprising IUDs in the region.

Some of the major market players include names such as CooperSurgical Inc. (CooperCompanies), Mylan N.V. (Viatris), and Allergan (AbbVie, Inc.), among others.

U.S. Intrauterine Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 4
  • Tables & Figures: 298
  • Countries covered: 1
  • Pages: 210
 Download Free Sample